Table of Contents
Preface Sheila Spada and Lorenzo Galluzzi 1. Circulating biomarkers for diagnosis and response to therapies in cancer patients Nat�lia Marc�li Stefanes, Maria Eduarda Cunha-Silva, Lisandra de Oliveira Silva, Laura Otto Walter, Maria Cl�udia Santos-Silva, and Manas Ranjan Gartia 2. Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients Ronan W. Hsieh, Lynn K. Symonds, Jason Siu, and Stacey A. Cohen 3. Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients Pooja Ratre, Suresh Thareja, Pradyumna Kumar Mishra 4. Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer Sabareeswaran Krishnan, Shruthi Kanthaje, Punchappady Devasya Rekha, M. Mujeeburahiman, and Chandrahas Koumar Ratnacaram 5. Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma Queenie Fernandes, Abdul W. Ansari, Karama Makni-Maalej, Maysaloun Merhi, Said Dermime, Aamir Ahmad, and Shahab Uddin 6. Nectin-4: A promising prognostic marker and therapeutic target in cancer Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, Zahwa Mariyam, Queenie Fernandes, Mohsin Maqbool, Omar M. Khan, Ajaz A. Bhat, and Shahab Uddi
